---
title: "AbSci (ABSI) Receives a Rating Update from a Top Analyst"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286159023.md"
description: "Debanjana Chatterjee from JonesTrading has maintained a Buy rating on AbSci (ABSI) with a price target of $11.00. Chatterjee, who focuses on the Healthcare sector, has an average return of 53.2% and a success rate of 75.97% on recommended stocks. Additionally, H.C. Wainwright reiterated a Buy rating on AbSci with a price target of $8.00."
datetime: "2026-05-12T21:05:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286159023.md)
  - [en](https://longbridge.com/en/news/286159023.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286159023.md)
---

# AbSci (ABSI) Receives a Rating Update from a Top Analyst

In a report released today, Debanjana Chatterjee from JonesTrading maintained a Buy rating on AbSci, with a price target of $11.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Chatterjee covers the Healthcare sector, focusing on stocks such as Spyre Therapeutics, EyePoint Pharmaceuticals, and KalVista Pharmaceuticals. According to TipRanks, Chatterjee has an average return of 53.2% and a 75.97% success rate on recommended stocks.

In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $8.00 price target.

### Related Stocks

- [ABSI.US](https://longbridge.com/en/quote/ABSI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md)
- [EYPT.US](https://longbridge.com/en/quote/EYPT.US.md)
- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)

## Related News & Research

- [HC Wainwright Has Optimistic Outlook of Absci Q3 Earnings](https://longbridge.com/en/news/286260136.md)
- [Absci to present at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/287060856.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)